Literature DB >> 10602876

Highly conserved antigen-presenting function of CD1d molecules.

L Brossay1, M Kronenberg.   

Abstract

The lack of polymorphism of nonclassical antigen-presenting molecules has led to the proposal that they may carry out some conserved and essential antigen-presenting function. Although this is a plausible hypothesis, the major histocompatibility complex has undergone dramatic expansions and contractions through evolution, and there is surprisingly little evidence for interspecies conservation of nonclassical class I molecules. The CD1d molecule, by contrast, shows an extremely high degree of functional conservation between mice and humans, with regard to its interaction with the relatively invariant TCRs that are expressed by NK T cells. This conservation for CD1d recognition is observed either in the absence of exogenous Ag or together with a lipoglycan antigen. The close functional and phenotypic conservation of NK T cells, in mammalian species separated by approximately 50 million years, suggests an essential role in the immune system for CD1d recognition by NK T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602876     DOI: 10.1007/s002510050590

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  18 in total

1.  Differential expression of ovine CD1.

Authors:  S M Rhind; J Hopkins; E S Grant
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

2.  The crystal structure of avian CD1 reveals a smaller, more primordial antigen-binding pocket compared to mammalian CD1.

Authors:  Dirk M Zajonc; Harald Striegl; Christopher C Dascher; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

3.  Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides.

Authors:  Karl O A Yu; Jin S Im; Alberto Molano; Yves Dutronc; Petr A Illarionov; Claire Forestier; Nagatoshi Fujiwara; Isa Arias; Sachiko Miyake; Takashi Yamamura; Young-Tae Chang; Gurdyal S Besra; Steven A Porcelli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-18       Impact factor: 11.205

4.  Elevated proportion of natural killer T cells in periodontitis lesions: a common feature of chronic inflammatory diseases.

Authors:  K Yamazaki; Y Ohsawa; H Yoshie
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

5.  CD1a and CD1d genes polymorphisms in breast, colorectal and lung cancers.

Authors:  Hossein Golmoghaddam; Abdul Mohammad Pezeshki; Abbas Ghaderi; Mehrnoosh Doroudchi
Journal:  Pathol Oncol Res       Date:  2011-01-22       Impact factor: 3.201

6.  Human leukemic cells loaded with alpha-galactosylceramide (alpha-GalCer) activate murine NKT cells in situ.

Authors:  Kanako Shimizu; Michihiro Hidaka; Kara Bickham; Mina Moriwaki; Koji Fujimoto; Fumio Kawano; Shin-ichiro Fujii
Journal:  Int J Hematol       Date:  2010-06-16       Impact factor: 2.490

7.  Prevention of NKT cell activation accelerates cutaneous wound closure and alters local inflammatory signals.

Authors:  David F Schneider; Jessica L Palmer; Julia M Tulley; Elizabeth J Kovacs; Richard L Gamelli; Douglas E Faunce
Journal:  J Surg Res       Date:  2010-04-07       Impact factor: 2.192

8.  Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells.

Authors:  Jing Wang; Yali Li; Yuki Kinjo; Thien-Thi Mac; Darren Gibson; Gavin F Painter; Mitchell Kronenberg; Dirk M Zajonc
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-30       Impact factor: 11.205

9.  Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma.

Authors:  Irina V Tiper; Tonya J Webb
Journal:  Cancer Immunol Immunother       Date:  2016-09-10       Impact factor: 6.968

10.  Human CD4- invariant NKT lymphocytes regulate graft versus host disease.

Authors:  Tereza Coman; Julien Rossignol; Maud D'Aveni; Bettina Fabiani; Michael Dussiot; Rachel Rignault; Joel Babdor; Marie Bouillé; André Herbelin; Francine Coté; Ivan C Moura; Olivier Hermine; Marie-Thérèse Rubio
Journal:  Oncoimmunology       Date:  2018-08-23       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.